Unexpectedly, it failed to show significant efficacy in the treatment of rheumatoid arthritis in a phase IIb clinical study, suggesting that the P2X7 receptor is not a therapeutically useful target in rheumatoid arthritis [166]. Here, P2RX7 is linked to rheumatoid arthritis.